4JQX
HLA-B*44:03 in complex with Epstein-Barr virus BZLF1-derived peptide (residues 169-180)
Experimental procedure
| Experimental method | SINGLE WAVELENGTH | 
| Source type | SYNCHROTRON | 
| Source details | AUSTRALIAN SYNCHROTRON BEAMLINE MX1 | 
| Synchrotron site | Australian Synchrotron | 
| Beamline | MX1 | 
| Temperature [K] | 100 | 
| Detector technology | CCD | 
| Collection date | 2008-10-06 | 
| Detector | ADSC QUANTUM 210r | 
| Wavelength(s) | 0.95668 | 
| Spacegroup name | P 21 21 21 | 
| Unit cell lengths | 50.816, 81.619, 110.336 | 
| Unit cell angles | 90.00, 90.00, 90.00 | 
Refinement procedure
| Resolution | 38.275 - 1.900 | 
| R-factor | 0.1965 | 
| Rwork | 0.195 | 
| R-free | 0.23110 | 
| Structure solution method | MOLECULAR REPLACEMENT | 
| Starting model (for MR) | 1sys | 
| RMSD bond length | 0.007 | 
| RMSD bond angle | 1.052 | 
| Data reduction software | MOSFLM | 
| Data scaling software | SCALA | 
| Phasing software | PHASER | 
| Refinement software | PHENIX ((phenix.refine: 1.7.3_928)) | 
Data quality characteristics
| Overall | Outer shell | |
| Low resolution limit [Å] | 40.180 | 2.000 | 
| High resolution limit [Å] | 1.900 | 1.900 | 
| Rmerge | 0.147 | 0.569 | 
| Number of reflections | 35075 | |
| <I/σ(I)> | 8.3 | 2.6 | 
| Completeness [%] | 95.5 | 97.1 | 
| Redundancy | 5.9 | 5.6 | 
Crystallization Conditions
| crystal ID | method | pH | temperature | details | 
| 1 | VAPOR DIFFUSION, HANGING DROP | 5.6 | 293 | 0.1 M citrate, pH 5.6, 0.2 M ammonium acetate, 16-26% PEG4000, VAPOR DIFFUSION, HANGING DROP, temperature 293K | 






